Jesper Krogh

Jesper Krogh serves as a Clinical Professor within the Department of Clinical Medicine at the University of Copenhagen, specializing in Internal Medicine: Endocrinology. His clinical and research activities are centered at Copenhagen University Hospital, with direct contact via phone (+4525535485) and email (jekrog@regionsjaelland.dk) at Blegdamsvej 3, 2200 Copenhagen N.

His primary research domains include:

• Endocrinology (focusing on diabetes subtypes and hormonal disorders)
• Diabetes pathophysiology and treatment (particularly MODY3 and SGLT2 inhibitors)
• Neuroendocrinology and brain metabolism interactions
• Metabolic disorders in cardiovascular contexts
• Neuroendocrine tumor management

Analysis of his 43 research outputs reveals a pronounced emphasis on translational endocrinology, with 2024-2025 publications predominantly investigating SGLT2 inhibitor efficacy in genetic diabetes forms, primary aldosteronism diagnostics, insulin resistance mechanisms, and neuroendocrine tumor outcomes. His work frequently employs clinical trial designs and systematic reviews, often in collaboration with the Copenhagen Neuroendocrine Tumour Centre, targeting therapeutic advancements for complex endocrine conditions.

No scientific awards are documented in the provided materials.

While student mentorship details are absent from the text, his collaborative publications with institutions like Region Zealand indicate active clinical supervision. Grant funding specifics remain undisclosed, though his research scope suggests involvement in diabetes and oncology-focused funding initiatives.

Dr. Krogh maintains strong institutional ties to the Copenhagen Neuroendocrine Tumour Centre, evidenced by co-authorship on multiple tumor studies, and participates in multidisciplinary teams addressing endocrine malignancies and metabolic disorders.